Skip to content
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
Novavax
Novavax Covid-19 vaccine performs well in clinical trials, but variables are still at risk
Novavax stock jerseys on final data from UK vaccine test
The Novavax vaccine shows 96% efficacy against primary coronavirus strain, 86% vs. UK variant
Pfizer will test the third dose of vaccine to protect against changes
AstraZeneca Covid-19 vaccine effectively against UK variants in trial
Two new vaccines show less effectiveness against the South African species
Global stocks will not stop falling as GameStop-Fueled volatility
Moderna will release details of new vaccine markets as Novavax moves to level 3
Explanation: Where are we in the Covid-19 vaccine race?
/https://specials-images.forbesimg.com/imageserve/6050ef67f0aedd1e1ae290cc/0x0.jpg?fit=300%2C300&ssl=1 "Novavax Covid-19 vaccine performs well in clinical trials, but variables are still at risk")
/https://specials-images.forbesimg.com/imageserve/5ffcd9aeb1259390874832a9/0x0.jpg?fit=300%2C300&ssl=1 "Moderna will release details of new vaccine markets as Novavax moves to level 3")
